Home

Ken Keyong Ren

CIK 1545181 · Chief Executive Officer · last filed 2019-06-21

Ken Keyong Ren is a Chief Executive Officer who has filed 12 SEC Form 4 insider transactions across 2 companies since 2012. The most recent filing, for CASI, was dated Jun 21, 2019. Across all open-market trades the lifetime net is +$10.9K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

12

Lifetime Open-Market Net

$10.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CASI Pharmaceuticals, Inc. (CASI) Delisted Chief Executive Officer 7,537 $0.28 $2.1K $10.9K 10 2019-06-21
CASI Pharmaceuticals, Inc. (ENMD) Delisted Chief Executive Officer — — — $0 2 2013-05-31

Recent Filings

12 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-06-21 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2019-01-31 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2018-12-06 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2016-10-05 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2016-06-27 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2016-06-03 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2016-03-04 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2016-01-21 CASI Pharmaceuticals, Inc. (CASI) Delisted Buy (P) +15,000 $10.9K EDGAR
2015-04-08 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2014-11-14 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 12
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.